Bellevue Hospital pharmacy residency wins eight-year national accreditation

NYC Health + Hospitals/Bellevue said on Oct. 23, 2026, that its Postgraduate Year One Pharmacy Residency Program has received eight-year national accreditation from the American Society of Health-System Pharmacists, the group’s full term, running through 2034.

What the accreditation means

According to the hospital, the result came after a comprehensive review of the residency’s training, education and compliance with national standards for postgraduate pharmacy education. Bellevue said the decision recognizes the strength of the program and its role in preparing pharmacists to provide safe, effective and patient-centered care.

The accreditation followed an ASHP survey in May 2026. ASHP’s Board of Directors accepted the Commission on Credentialing’s decision in September 2026.

• Program: Bellevue Hospital PGY1 Pharmacy Residency
• Accrediting body: American Society of Health-System Pharmacists
• Term: Eight years
• End date: 2034
• Survey month: May 2026
• Board approval: September 2026

Training across major areas of care

Bellevue said its 52-week residency offers advanced clinical training in internal medicine, emergency medicine, critical care, infectious diseases and ambulatory care. Residents work with interdisciplinary teams and take part in medication safety efforts, quality improvement work, research, teaching and professional development.

According to the release, the program is designed to help pharmacists handle complex medication therapy, strengthen patient safety and continue into advanced clinical practice or additional specialty training.

Residents also train at a major public academic medical center serving one of New York City’s most diverse patient populations, Bellevue said.

Leaders say the program supports the workforce

Bellevue Chief Executive Officer Eric Wei, MD, MBA, said the accreditation reflects the hospital’s commitment to both patient care and clinical education. He said the hospital has a responsibility to care for New Yorkers now and help prepare the health professionals who will serve communities in the future.

Chief Operating Officer Erfan Karim, MPH, said the recognition shows the rigor of the residency and the work of the pharmacists who teach and mentor residents. Deputy Chief Pharmacy Officer Beverly Morgan, PharmD, said the program gives residents the clinical knowledge, critical-thinking skills and professional confidence needed to work effectively on care teams.

Residency Program Director Andrew Straznitskas, PharmD, BCCCP, said the eight-year term is a sign of the effort and collaboration of the pharmacy team. He said the goal is to train residents to think critically, make evidence-based decisions and provide high-quality care to patients with complex needs.

Why it matters to patients and families

For ordinary readers, the accreditation signals that Bellevue’s pharmacy residency has met a high national standard for training pharmacists. That can matter in a hospital where medication safety, coordination among clinicians and care for complex conditions are part of daily work.

As Bellevue described it, the program helps develop the next generation of pharmacists in a setting focused on collaboration, continuous learning and patient safety. The hospital said the recognition also strengthens its role in education and workforce development within NYC Health + Hospitals, the city’s public hospital system.

Source: NYC Health + Hospitals